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Summary
We report here on the generation of a new fluorescent protein reporter transgenic mouse line, 
Col10a1-mCherry, which can be used as a tool to study chondrocyte biology and pathology. 
Collagen, Type X, alpha 1 (Col10a1) is highly expressed in hypertrophic chondrocytes and 
commonly used as a gene marker for this cell population. The Col10a1-mCherry reporter line was 
generated using a bacterial recombination strategy with the mouse BAC clone RP23-192A7. To 
aid in the characterization of this animal model, we intercrossed Col10a1-mCherry mice with 
Collagen, Type II, alpha 1 (Col2a1) enhanced cyan fluorescent protein (ECFP) reporter mice and 
characterized the expression of both chondrocyte reporters during embryonic skeletal development 
from days E10.5 to E17.5. Additionally, at postnatal day 0, Col10a1-mCherry reporter expression 
was compared to endogenous Col10a1 mRNA expression in long bones and revealed that mCherry 
fluorescence extended past the Col10a1 expression domain. However, in situ hybridization for 
mCherry was consistent with the zone of Col10a1 mRNA expression, indicating that the persistent 
detection of mCherry fluorescence was a result of the long protein half life of mCherry in 
conjunction with a very rapid phase of skeletal growth and not due to aberrant transcriptional 
regulation. Taking advantage of the continued fluorescence of hypertrophic chondrocytes at the 
chondro-osseus junction, we intercrossed Col10a1-mCherry mice with two different Collagen, 
Type 1, alpha 1, (Col1a1) osteoblast reporter mice, pOBCol3.6-Topaz and pOBCol2.3-Emerald to 
investigate the possibility that hypertrophic chondrocytes transdifferentiate into osteoblasts. 
Evaluation of long bones at birth suggests that residual hypertrophic chondrocytes and osteoblasts 
in the trabecular zone exist as two completely distinct cell populations. genesis 49:410–418, 2011.
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INTRODUCTION
Cartilage formation occurs during endochondral ossification in the appendicular skeleton, 
axial skeleton and cranial base, where embryonic mesenchyme condenses and differentiates 
to form a cartilaginous anlagen that, in part, serves as a template for bone formation (Hall 
and Miyake, 2000). Signaling between the cartilaginous anlagen and outer perichondrium 
has been an area of great interest, where morphogenetic changes in the anlagen result in 
joint formation and bone formation at defined, but disparate locations. During these early 
stages of skeletal development, chondrocytes organize as a growth plate and undergo a well-
defined program of differentiation whose characteristic stages are referred to as: resting or 
reserve, proliferative, prehypertrophic, and hypertrophic.
Early studies in skeletal biology revealed changes in collagen gene expression during 
chondrocyte maturation. Collagen, Type 2, alpha 1 (Col2a1) is abundantly expressed in 
immature chondrocytes, but then down regulated during maturation. In contrast, Collagen, 
Type 10, alpha 1 (Col10a1) expression is absent in immature chondrocytes, but becomes 
highly expressed in mature hypertrophic chondrocytes (Castagnola et al., 1988; Iyama et al., 
1991). An increasing body of evidence has indentified many of the signaling pathways 
involved in regulating chondrocyte differentiation. Parathyroid hormone related protein 
(PTHrP) and fibroblast growth factor 18 (FGF18) signaling promote chondrocyte 
proliferation and block maturation (Lanske et al., 1996; Liu et al., 2002; Vortkamp et al., 
1996) while bone morphogenetic protein (BMP), Wnt, and retinoic acid signaling promote 
chondrocyte maturation in part through runt related transcription factor 2 (RUNX2) (Drissi 
et al., 2003; Enomoto-Iwamoto et al., 1998; Enomoto et al., 2000; Li et al., 2003; Yasuhara 
et al., 2010). Additionally, Indian hedgehog (IHH) functions as a central organizer with 
direct and indirect roles in chondrocyte proliferation and differentiation, as well as initiating 
osteoblast differentiation on the outer perichondrium (Kobayashi et al., 2005; Minina et al., 
2001, 2002; St-Jacques et al., 1999; Vortkamp et al., 1996).
Past studies have sought to define mechanisms of Col10a1 transcriptional regulation. Cis 
elements providing enhancer and repressor functions have been identified in human, mouse, 
and chick Col10a1 genes (Beier et al., 1997; Chambers et al., 2002; Harada et al., 1997; 
Leboy et al., 2001; Riemer et al., 2002; Thomas et al., 1995; Volk et al., 1998). Additionally, 
in vitro biochemical studies have revealed a host of factors that are potentially involved in 
the direct positive regulation of Col10a1 transcription including: RUNX2, AP-1 factors, 
LEF/TCFs, and SMADs, which are involved in Wnt, BMP, and retinoic acid signaling 
pathways that promote chondrocyte maturation (Drissi et al., 2003; Enomoto et al., 2000; 
Gebhard et al., 2008; Li et al., 2003; Riemer et al., 2002; Volk et al., 1998; Yasuhara et al., 
2010). Despite the successful identification of cis and trans regulatory elements required for 
Col10a1 expression, past transgenic studies that have utilized a defined Col10a1 promoter 
region to drive the expression of a β-galactosidase reporter or a Cre recombinase suggested 
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additional cis regulatory elements were required to recapitulate endogenous Col10a1 
transcription (Gebhard et al., 2004; Yang et al., 2005). With this in mind, a Col10a1 BAC 
clone proved sufficient to drive robust and specific expression of a β-galactosidase reporter 
and a Cre recombinase in hypertrophic chondrocytes (Gebhard et al., 2007, 2008).
We report here on the generation and characterization of Col10a1-mCherry fluorescent 
protein reporter mice. The Col10a1 transgenic construct was created using mouse BAC 
clone RP23-192A7, which was previously determined to direct accurate expression of 
Col10a1 (Gebhard et al., 2007, 2008). A recombinase A (RecA) bacterial recombination 
system was used to insert mCherry fluorescent protein just upstream of the translation start 
site (see Fig. 1) (Gong et al., 2002). Six transgenic founder lines were initially generated. 
After a preliminary assessment of reporter gene expression, our two highest expressing lines 
were maintained thereafter.
To aid in the characterization of Col10a1-mCherry mice, we capitalized on the existence of 
Col2a1-ECFP and Col1a1 fluorescent protein reporter (pOBCol3.6-Topaz and 
pOBCol2.3Emerald) mouse lines. Both Col2a1 and Col1a1 reporter mice use fluorescent 
protein reporters that are spectrally distinct from mCherry allowing us to simultaneously 
image immature chondrocytes and hypertrophic chondrocytes and/or osteoblasts and 
hypertrophic chondrocytes, respectively. The generation of Col2a1-ECFP mice was recently 
reported (Chokalingam et al., 2009a,b) and was constructed in a fashion similar to Col2a1-
EGFP mice (Grant et al., 2000). We characterized the expression of Col10a1-mCherry in 
relation to Col2a1-ECFP during embryonic skeletal development from E10.5 to E17.5 (see 
Fig. 2). Col2a1-ECFP expression was detected at E10.5, well before Col10a1-mCherry 
expression in the developing somites, brachial arch 1, and craniofacial primordia covering 
the ventral forebrain (Fig. 2A). At E12.5, Col2a1-ECFP expression defines much of the 
early-forming axial and appendicular skeleton where condensing vertebral bodies along the 
axial skeleton and areas of cartilage condensations in both forelimb and hindlimb express 
the ECFP reporter, but Col10a1-mCherry expression still cannot be observed at this stage 
(Fig. 2B). At E14.5, (Fig. 2C,D) Col2a1-ECFP expression was seen in the developing ears, 
ribs, vertebrae, and long bones of the appendicular skeleton. However, expression of the 
Col2a1 reporter was not observed in the joint spaces and in regions of the anlagen 
undergoing maturation where Col10a1-mCherry expression was now observed. Both lateral 
(Fig. 2C) and dorsal (Fig. 2D) views showed Col10a1 reporter expression in the ribs and at 
the center of the anlagen in long bones of the appendicular skeleton where chondrocytes 
undergo hypertrophy. By E17.5 (Fig. 2E–H) Col2a1 and Col10a1 driven reporter genes 
sharply illuminated much of the embryonic skeleton. Col2a1 reporter expression was seen in 
the ears and cranial base of the skull, in the ventral part of the rib cage and vertebral bodies 
of the spine, and at the proximal and distal ends of long bones of the appendicular skeleton 
(Fig. 2E,G,H, blue). Col10a1 reporter expression was observed in the dorsal half of the rib 
cage and in symmetrical points of hypertrophy along the vertebrae (Fig. 2F,H, red). In the 
long bones of the appendicular skeleton, Col10a1 reporter expression domains lay adjacent 
and interior to Col2a1 expressing chondrocytes (Fig. 2F,G). To appreciate the temporal 
changes that occur during long bone formation, we imaged forearm development at higher 
magnification from E12.5 to E17.5 (Fig. 2I–K). At E12.5 Col2a1-ECFP expression can be 
observed at sites of chondrocyte condensation (Fig. 2I). At E14.5, a single Col10a1-mCherry 
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expression zone was seen at the center of anlagen in the humerus, radius, ulna, and digits 
(Fig. 2J). By E17.5 the Col10a1 expression zone has separated into two domains with a gap 
in between where hypertrophic chondrocytes are undergoing apoptosis, promoting the 
formation of a marrow cavity, and leaving a mineralized template upon which trabecular 
bone will form (Fig. 2K). Tissue sections through the forearm of E17.5 mice (Fig. 2L–O) 
showed some overlapping expression between Col2a1 and Col10a1 reporters in the growth 
plate (Fig. 2O). Col2a1 reporter expression can be seen throughout the resting and 
proliferative zones, but was down regulated in the hypertrophic zone (Fig. 2L). Col10a1 
reporter expression is absent from the resting and proliferative zones, but robustly expressed 
in chondrocytes undergoing hypertrophy (Fig. 2M).
To further characterize the expression of Col10a1-mCherry reporter mice, we compared 
reporter gene expression to endogenously expressed Col10a1 mRNA at postnatal day 0 (P0) 
in long bones (Fig. 3, compare A with B). As anticipated, endogenous Col10a1 mRNA was 
largely restricted to the hypertrophic zone (HZ) (Fig. 3B, tibia). Interestingly, while 
Col10a1-mCherry reporter expression was detected in the hypertrophic zone, the 
fluorescence of the reporter actually intensified as hypertrophic cells became part of the 
bone marrow (BM) (Fig. 3A). To clarify whether this was aberrant transcriptional regulation 
of our transgenic DNA construct, we carried out an in situ for mCherry mRNA (Fig. 3D, 
fibula). However, mCherry mRNA expression was largely restricted to the hypertrophic zone 
like Col10a1 mRNA, while mCherry protein fluorescence extended from the hypertrophic 
zone into the bone marrow (Fig. 3C). On the other hand, at adult ages mCherry fluorescence 
is largely restricted to the hypertrophic zone and substantially less is observed in the bone 
marrow trabecular region (data not shown). Therefore, we conclude that the transcriptional 
regulation of our reporter is accurate, but the long protein half-life of mCherry (~24 hours) 
allows for the continued marking of hypertrophic chondrocytes at a very active stage of 
skeletal growth. Consistent with hypertrophic chondrocytes undergoing programmed cell 
death, much of the mCherry fluorescence we observed in the bone marrow appeared as cell 
debris particularly as the distance from the growth plate into the bone marrow space 
increased (Fig. 3E, white arrows). However, we also observed a diverse range of cellular 
phenotypes that we speculate are hypertrophic cells at different stages of cell death. Among 
this complex environment, we occasionally observed mCherry positive cells within the 
trabecular region that looked relatively intact, retained nuclei as determined by DAPI 
staining, and showed high mCherry fluorescence (Fig. 3E, and imaged at lower exposure in 
Fig. 3F, cells marked by an asterisk). Previous studies have also commented on the existence 
of hypertrophic chondrocytes that seem to evade apoptosis (Gebhard et al., 2007). While the 
reason for increased mCherry fluorescence as hypertrophic chondrocytes meet and mix with 
bone marrow cells is not clear, we speculate that it is related to the changing physiology of 
hypertrophic chondrocytes.
The continued marking of intact hypertrophic chondrocytes within the trabecular region of 
bone by the mCherry reporter suggested the possibility that these cells may be a rare 
population of hypertrophic chondrocytes that further differentiate into osteoblasts as an 
alternative to apoptosis. The topic of hypertrophic chondrocytes differentiating into 
osteoblasts has been speculated upon for years (Kahn and Simmons, 1977; Moskalewski and 
Malejczyk, 1989; Thesingh et al., 1991) and has been the subject of different review articles 
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(Adams and Shapiro, 2002; Shapiro et al., 2005; Wlodarski et al., 2006). To explore the 
possibility of chondrocyte to osteoblast transdifferentiation, we crossed Col10a1-mCherry 
mice with two different osteoblast reporter mouse lines, pOBCol3.6-Topaz and pOBCol2.3-
Emerald (see Fig. 4), which have been extensively used to study osteoblast biology (Bilic-
Curcic et al., 2005; Kalajzic et al., 2002, 2005; Ushiku et al., 2010). We reasoned that the 
persistent detection of Col10a1-mCherry fluorescence in cells present within the trabecular 
bone region may be used in a developmental fate mapping-like scheme and allow us to 
detect skeletal cells that express both chondrocyte and osteoblast reporters. However, 
examination of long bones at P0 from triple (Col2a1-ECFP, Col10a1-mCherry, and 
pOBCol3.6-Topaz) (Fig. 4A–D) and dual (Col10a1-mCherry and pOBCol2.3-Emerald) (Fig. 
4E–H) transgenic mice showed no evidence of cell populations expressing both chondrocyte 
and osteoblast reporters. While Col10a1-mCherry positive cells (Fig. 4B,F, yellow arrow 
heads) and pOBCol3.6-Topaz (Fig. 4C) or pOBCol2.3-Emerald (Fig. 4G) positive 
osteoblasts (white arrow heads) could be seen amongst each other (Fig. 4D,H), both cell 
populations were entirely distinct. Since this is not a true genetic fate mapping scheme, we 
cannot completely rule out the possibility of transdifferentiation. However, given the clear 
distinction of chondrocyte and osteoblast cell types at this very active stage of skeletal 
development, we believe that transdifferentiation is unlikely to be a natural process.
Numerous pathological conditions exist that directly involve cartilage, including genetically 
inherited disorders, sports induced injuries, and age related deterioration. Genetic 
manipulation of the mouse is a common strategy to study gene function, to model different 
pathological conditions, and to test regenerative therapies. Here we have introduced the 
generation Col10a1-mCherry transgenic reporter mice that will serve as a valuable tool to 
study chondrocyte development, damage, and repair. To aid in the characterization of this 
animal model and increase our understanding of chondrocyte biology, we crossed Col10a1-
mCherry mice with Col2a1-ECFP, pOBCol3.6-Topaz, and pOBCol2.3-Emerald mice. The 
combinatorial use of spectrally-distinct fluorescent protein reporters enables the 
intercrossing of different fluorescent protein reporter lines to further resolve cell types, 
mechanisms of development, and tissue regeneration.
MATERIALS AND METHODS
DNA Constructs
BAC Clone RP23-192A7 was obtained from Children’s Hospital Research Institute 
(CHORI). PLD53.SC2 and PSV1.RecA vectors were kindly provided by Shiaoching Gong 
(Gong et al., 2002).
Assembly of the Col10a1-mCherry Reporter
A 453bp homology arm was PCR amplified from purified RP23-192A7 using primers: 
Col10a1 5′Not1 (Sense) 5′-TCTCGCGGCCGCGTACCCAGACAGGTTCATTTGT 
ATTGATCT-3′ and Col10a1 3′ BamH1 (antisense) 5′-
CTCTGGATCCTTTCAGATAGATTCTGAAAAGCAGAAGA GAATC-3′. The PCR 
amplicon was cloned into Not1 and BamH1 sites of the pLD53.sc2-mCherry shuttle vector 
using standard cloning methods. Recombinase A was introduced into RP23-192A7 host 
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bacteria by transformation with pSV1.RecA vector (100 ng) and selected for on 
chloramphenicol (12.5 ug/ml)/tetracycline (10ug/ml) LB agar plates. RP23-192A7 host 
bacteria containing RecA were then transformed by electroporation with 1 μg (1–2 μl) of the 
pLD53.sc2-mCherry containing the Col10a1 homology arm. SOC medium (1 ml) was added 
and transformed bacteria were incubated with shaking at 200 rpm for one hour at 30°C. 
Recombinants were first selected for by adding 5 ml of LB medium containing 
chloramphenicol (12.5 μg/ml), ampicillin (50 μg/ml), and tetracycline (10 μg/ml) to bacteria 
and grown overnight at 30°C with shaking at 200 rpm. Further selection for recombinant 
clones was carried out by plating 100 μl of overnight culture on to chloramphenicol (12.5 
μg/ml), ampicillin (50 μg/ml) LB agar plates and incubated overnight at 42°C. 
Chloramphenicol/ampicillin resistant colonies were screened by colony PCR using primers 
that flank the Col10a1 homology arm: Col10a1 5′ Recom (sense) 5′-
CCTGCCAGCAGGCTTGGAAACAGGCTTCA-3′ and mCherry 3′ (antisense) 5′-
GCACCTTGAAGCGCATGAACTCCTTGATGA-3′. Colony PCR identified candidate 
recombinants were further verified by diagnostic restriction enzyme digestion with Sal1 and 
Pvu1 and field inversion gel electrophoresis.
BAC DNA Preparation for Pronuclear Injection
The Col10a1-mCherry BAC construct was purified from a 200-ml culture using a Maxi Kit 
(Qiagen) with minor modifications. During alkaline lysis, 2M potassium acetate was used in 
place of the 3M solution. Additionally, after elution with QF buffer, two phenol/chloroform 
extractions followed by one chloroform extraction were carried out to further clean up the 
BAC DNA. BAC DNA (10 μg) was then linearized with PI-SceI restriction enzyme for 2 
hours and loaded onto a CL-4B Sepharose (Sigma) column pre-equilibrated with injection 
buffer (10 mM Tris, pH7.5, 0.1 mM EDTA, 100 mM NaCl). Ten 300 μl fractions were 
collected from the column and DNA concentrations were measured with a Nanodrop 
Spectrophotometer (Thermo-Scientific). Thirty microliters of each fraction were also run on 
a field inversion gel to assess the DNA quality. Pronuclear injection was carried out at the 
UCONN Health Center Gene Targeting and Transgenic Facility.
Probe Synthesis for In Situ Hybridization
BAC clone RP23-192A7 containing the Col10a1 gene and PLD53.sc2-mCherry plasmid 
were used to synthesize a Col10a1 probe (733 bp) and mCherry probe (741 bp), respectively. 
PCR primers for Col10a1 were: sense, 5′-GTAGGAGCTAAAGGAGTGCCTGGACAC-3′; 
anti-sense, 5′-GTGAGGAAACTTGGTCCCAGAGTGCAC-3′ and nested oligo, anti-sense, 
5′-ACGAGTGGACGTACTCAGAGGAGTAG-3′. PCR primers for mCherry were: sense, 
5′-GGAG GATAACATGGCCATCATCAAGG-3′; anti-sense, 5′-CGTAC 
TGTTCCACGATGGTGTAGTCCTCG-3′. The final PCR reaction for probe synthesis was 
done only with the antisense oligo to generate single-stranded DNA (ssDNA) probes in the 
presence of digoxigenin-11-dUTP (Roche) as previously described (O’Connell, 2002). 
Synthesized probes were further cleaned up using PCR purification columns (Qiagen).
In Situ Hybridization
Frozen tissue sections were first fixed in 4% paraformaldehyde (PFA) at room temperature 
for 10 min and then incubated in 3% H2O2/PBS for 10 min to quench endogenous 
Maye et al. Page 6





















peroxidase activity. After proteinase K treatment (1 μg/ml in Tris-HCl/0.05M EDTA) for 10 
min, sections were further permeabilized in 0.1% Triton X-100 for 10 min. Sections were 
then refixed in 4% PFA for 5 min. Sections were washed three times (5 min/wash) with PBS 
and dehydrated in 70% ethanol for 5 min followed by brief washes in 80%, 90%, and 100% 
ethanol before hybridization. Hybridization buffer: (50% formamide, 10% dextran sulfate, 
1% Denhardt’s, 250 μg/ml yeast tRNA, 0.3M NaCl, 20mM Tris-Cl (pH 8.0), 5mM EDTA 
(pH 8.0), 10mM NaPO4 (pH 8.0), 1% Sarkosyl). Single-stranded DNA probes were diluted 
in hybridization buffer (1:200). Hybridization was then carried out in a humidified chamber 
at 55°C for 18 hours. After hybridization sections went through sequential wash steps: 30 
min in 50% formamide in 2× SSC at 65°C, 15 min in 2× SSC at 37°C, 15 min in 0.1× SSC 
at 37°C, and 15 min in TNT buffer (0.1M Tris-Cl pH 7.5, 0.15M NaCl, and 0.05% 
Tween-20). After blocking in 0.5% blocking reagent (PerkinElmer, FP1020) in TNT buffer 
for 1 hour, the hybridized ssDNA probes were detected by incubating 30 min with 
antidigoxigenin-POD, Fab fragment (1:100) (Roche). Digoxigenin labeled probe was 
detected by incubating 10 min in 1:50 TSA plus Fluorescein (PerkinElmer) and washed 
three times in TNT buffer before visualization.
Imaging of Reporter Gene Mice
Whole embryo imaging was carried out on a Zeiss Lumar stereomicroscope. Tissues 
sections were imaged using a Zeiss Imager Z.1 upright microscope. Filter sets (Chroma 
Technology) to image fluorescent protein expression were as follows: ECFP: ET436/20× 
(excitation), ET480/40 m (emission), T455LP beam splitter, mCherry: ET577/20× 
(excitation), ET640/40 m (emission), Q595lp beam splitter, Emerald: ET470/40× 
(excitation), ET525/50 m (emission), T495 beam splitter, Topaz: ET500/20× (excitation), 
ET535/30 m (emission), T515LP beam splitter. Beam splitters were not part of the optics for 
stereomicroscope imaging.
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DNA construct map for Col10a1-mCherry. The Col10a1-mCherry reporter was made in 
BAC clone RP23-192A7. The fluorescent protein mCherry was inserted two nucleotides 
upstream of the Col10a1 translation start site (underlined sequence). A 453 bp homology 
arm (shown in green) was used to direct the recombination of mCherry into the BAC clone 
by homologous recombination in bacteria.
Maye et al. Page 11






















Reporter gene expression of Col2a1-ECFP (blue) and Col10a1-mCherry (red) transgenic 
mice during embryonic skeletal development. (A–H) Whole embryo imaging of reporter 
gene expression from E10.5 to E17.5. (A) Col2a1-ECFP expression at E10.5 in the 
developing somites, brachial arch1, and surface of the ventral forebrain. (B) Col2a1-ECFP 
expression at E12.5 in chondrocyte condensations of the limb bud and vertebral bodies. (C 
and D) Col2a1-ECFP and Col10a1-mCherry reporter expression at E14.5. Col2a1 reporter 
expression continues to be expressed in growing condensations. Initial expression of 
Col10a1 reporter expression was detected in the developing ribs adjacent to the spine and at 
the center of the anlagen in long bones of the forearm. (E–H) Col2a1-ECFP and Col10a1-
mCherry reporter expression at E17.5. Col2a1 and Col10a1 are expressed in largely distinct 
zones of cartilage maturation with Col2a1 reporter expression (E, G, H) being expressed in 
the proximal and distal ends of long bones and the ventral half of the rib cage and Col10a1 
reporter expression (F, G, H) occurring adjacent and interior to Col2a1 expression domains 
in long bones and the dorsal half of the rib cage. (I–K) Imaging of reporter gene expression 
in the forelimbs at E12.5, E14.5, and E17.5 days of development. (I) Col2a1 reporter 
expression initially appears throughout the cartilaginous anlagen of the forearm, but as 
chondrocytes mature Col2a1 expression was down regulated and Col10a1 reporter 
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expression was initiated (J). (K) By E17.5 Col2a1 expression was restricted to the proximal 
and distal ends of long bones and the single zone of hypertrophy marked by Col10a1 
reporter expression was also separated into two regions. (L–O) Tissue sections through the 
radius and ulna at E17.5 days of development. (L) Col2a1 reporter expression was seen in 
the resting and proliferative zone. (M) Col10a1 reporter expression was seen in the 
hypertrophic zone. (O) Col2a1 and Col10a1 reporter expression slightly overlap in the 
growth plate.
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Comparison of Col10a1-mCherry protein fluorescence to endogenous Col10a1 mRNA and 
mCherry mRNA. Col10a1-mCherry protein fluorescence (A) was compared to endogenous 
Col10a1 mRNA (B) in the proximal tibia at postnatal day 0. (C) Comparison of Col10a1-
mCherry protein fluorescence to mCherry mRNA (D) in the distal fibula at P0. (E) 
Visualization of mCherry fluorescence and DAPI stained nuclei in the bone marrow (BM) 
below the hypertrophic zone (HZ). mCherry fluorescent cell debris (white arrow heads) was 
scattered below the HZ, but an area containing mCherry positive cells with intact nuclei can 
been seen (boxed in region, marked by an asterisk). (F) Higher magnification of boxed 
region shown in E, mCherry positive cells contain nuclei (marked by an asterisk). (F) 
mCherry fluorescence was imaged at lower exposures than shown in (E) to better visualize 
individual cells with DAPI stained nuclei.
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No evidence for chondrocyte to osteoblast transdifferentiation. To determine if hypertrophic 
chondrocytes transdifferentiate into osteoblasts, femur (A–D) and tibia (E–H) section were 
examined from triple transgenic (A–D, Col2a1-ECFP, Col10a1-mCherry, and pOBCol3.6-
Topaz) and dual transgenic (E–H), Col10a1-mCherry and pOBCol2.3-Emerald) mice, 
retaining chondrocyte and osteoblast reporter genes. (A, E) Detection of chondrocyte and 
osteoblast reporters at low magnification showing a region of interest (boxed in area) 
magnified in the corresponding panels, (B–D for A, and F–H for E). Both regions are 
located at the boundary where the hypertrophic zone (HZ) ends and osteoblasts make 
trabecular bone (TB). While hypertrophic chondrocytes [mCherry positive—red (yellow 
arrow heads, panels B and F)] and osteoblasts [Topaz or Emerald positive—green (white 
arrow heads, panels C and G)] cell types were in close proximity to each other, they existed 
as two distinct cell populations and no cells expressed both chondrocyte and osteoblast 
reporters.
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